| 2025 |
An Investigation of the Anticancer Mechanism of Caesalpinia sappan L. Extract Against Colorectal Cancer by Integrating a Network Pharmacological Analysis and Experimental Validation |
| 2025 |
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab Versus Pembrolizumab Monotherapy for Stage Ⅳ Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial |
| 2024 |
Herbal Medicines for the Improvement of Immune Function in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| 2024 |
Trends in Current Clinical Research on Herbal Medicines and Gut Microbiota |
| 2024 |
Genome-wide Analysis Identified SEMA4D, Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung Cancer |
| 2024 |
Herbal Medicines for the Improvement of Immune Function in Patients with Cancer: A Protocol for Systematic Review and Meta-Analysis |
| 2024 |
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations |
| 2024 |
Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: A scoping review |
| 2024 |
Bojungikki-Tang Augments Pembrolizumab Efficacy in Human PBMC-Injected H460 Tumor-Bearing Mice |
| 2023 |
Sesquiterpene Lactones-Rich Fraction of Inula helenium L. Enhances the Antitumor Effect of Anti-PD-1 Antibody in Colorectal Cancer: Integrative Phytochemical, Transcriptomic, and Experimental Analyses |
| 2023 |
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial |
| 2023 |
Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngenic mouse model. |
| 2022 |
A Comprehensive Discussion in Vaginal Cancer Based on Mechanisms, Treatments, Risk Factors and Prevention |
| 2022 |
Bojungikki-Tang Improves Response to PD-L1 Immunotherapy by Regulating the Tumor Microenvironment in MC38 Tumor-Bearing Mice |
| 2022 |
Read Count Patterns and Detection of Cancerous Copy Number Alterations in Plasma Cell-Free DNA Whole Exome Sequencing Data for Advanced Non-Small Cell Lung Cancer |
| 2022 |
Novel Biomarkers in Lung cancer and Chronic Lung Diseases: Systematic Perspective from a Yin-Yang Balance |
| 2022 |
Investigating treatment response and immune profile in association with pattern identification in NSCLC patients scheduled for immune checkpoint inhibitor monotherapy (HARMONY study) |
| 2022 |
Bojungikki-Tang Enhances the Effect of PD-1 Blockade in a Syngeneic Murine Model of Lung Carcinoma |
| 2022 |
Identification of Zinc-Binding Inhibitors of Matrix Metalloproteinase-9 to Prevent Cancer Through Deep Learning and Molecular Dynamics Simulation Approach |
| 2021 |
The Current Status of Integrative Oncology in Korea |
| 2021 |
암 환자 대상 설문지, 맥진기, 설진기 결과를 활용한 한열허실변증에 대한 예비 연구 |
| 2021 |
A Pilot Study of Whether the Cold-Heat Syndrome Type is Associated with Treatment Response and Immune Status in Patients with Non-Small Cell Lung Cancer |
| 2019 |
The herbal drug, Bu-Zhong-Yi-Qi-Tang, for the treatment of atopic dermatitis |
| 2019 |
Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer |
